Recently, it has been clarified that interaction between hematopoietic cells and endothelial cells is important in normal hematopoiesis and leukemogenesis. In this study, we examined the relationship between AML cells and endothelial cells by analyzing the expression profile of angiogenic factors, angiopoietin-1 (Ang-1), Ang-2, Tie-2 (a receptor for angiopoietins) and vascular endothelial growth factor (VEGF). Our results demonstrated that CD7(؉)AML expressed Ang-2 mRNA frequently and integrin-family adhesion molecules (CD11c and CD18) intensively, suggesting the close correlation with endothelial cells. On the other hand, in t(8;21) AML cells, expression of Ang-2 was infrequent and expression of integrin-family adhesion molecules (CD11b, CD11c and CD18) was weak, suggesting the sparse association with endothelial cells. As for CD7(؉)AML cells, despite the frequent and intense expression of endothelial cell-associated molecules (such as Ang-2, CD11c and CD18), intensity of Tie-2 expression was quite low (P < 0.05). 
Introduction
Recently, it has been clarified that hematopoietic stem cells and endothelial cells originated from common precursor cell, hemangioblast. [1] [2] [3] In the normal developmental process, interaction between hematopoietic stem cells and endothelial cells is thought to be important. [4] [5] [6] Endothelial cells have been shown to produce many cytokines known to play a role in the proliferation and differentiation of hematopoietic progenitors. 4, 5 Conversely, it has been shown that hematopoietic stem cells play important roles for angiogenesis. 6 In addition, some reports suggested that leukemia cells also have intimate correlation with endothelium in bone marrow. Increased angiogenesis was seen in the bone marrow of acute and chronic leukemia patients, where some angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were implicated to be mediators. [7] [8] [9] The interaction between endothelial cells and normal or malignant hematopoietic cells is also mediated by adhesion molecules such as integrins, as well as soluble factors. 10, 11 Angiopoietins and VEGF are recognized to act coordinately during vascular growth and remodeling. Blood vessels remain in a stable state when Tie-2 receptor is constitutively engaged with angiopoietin-1 (Ang-1) by stabilizing blood vessels through interactions with perivascular cells and the extracellular matrix. When Ang-2 expression is up-regulated, the interaction between Tie-2 and Ang-1 is disrupted, and the vessel is destabilized. Endothelial cells, separated from support cells and matrix, become plastic and angiogenesis is promoted in the presence of VEGF. [12] [13] [14] [15] In addition, various types of cancer cells have been shown to produce factors stimulating angiogenesis in the tumor. 16, 17 Inhibitors for these angiogenic factors are now considered to be candidates for novel therapeutic tools for cancer. 18, 19 In this study, we would like to clarify the relationship between AML cells and endothelial cells by analyzing the expression profile of angiogenic factors, Ang-1, -2, Tie-2 and VEGF. Phenotype-and karyotype-specific expression pattern was observed. In addition, expression of integrin-family adhesion molecules also showed distinct pattern. Co-culture experiment of AML cells and human umbilical vein endothelial cells was done to investigate the functional interaction between AML cells and endothelial cells.
Materials and methods

Samples and cell lines
Bone marrow (BM) and peripheral blood (PB) smears were prepared for May-Grü nwald Giemsa, peroxidase, naphthol AS-D chloroacetate esterase, and ␣-naphthyl butylate esterase staining. The morphological diagnosis of AML was made according to FAB classification. Karyotypic analysis was performed on aspirated BM cells. All samples contained more than 80% leukemic cells morphologically. All patients gave their informed consent for the procedure involved. Leukemic cells from 36 AML patients including 12 M1, 12 M2, three M3, five M4 and four M5 cases were studied. In addition, 375 AML samples were studied for phenotypical study, especially of integrin-family adhesion molecules. An AML cell line, KG-1 and its subline, KG-1a (provided from Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University, Japan) were also studied. 
Cell separation
Immunophenotyping
Before immunostaining, MNC were treated with 1 mg/ml human ␥-globulin for blocking of the binding due to receptors for immunoglobulin G (IgG) Fc portion (Fc␥R). CD13 (recognized by My7, Coulter, Hialeah, FL, USA), and CD33 (by My9, Coulter) were tested as myeloid differentiation markers. CD7 (by M-T701, PharMingen, San Diego, CA, USA) and CD19 (by HIB19, PharMingen) were tested as lymphoid associated markers. CD34 (by HPCA-1, Becton Dickinson, Mountain View, CA, USA) was examined as stem cell marker. CD11b (by Leu15, Becton Dickinson), CD11c (by B-ly6, PharMingen), and CD18 (by 7E4, Immunotech, Marseille, France) were tested as integrin-family adhesion molecules. Fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse immunoglobulins was used as the second reagent. Samples were examined by a flowcytometer (FACSCalibur; Nippon Becton Dickinson, Tokyo, Japan). We focused on the leukemic cell fraction of the cytogram to clarify its phenotype, as previously described. 20 At least 5000 cells were examined in the surface marker study. The whole mouse Igs, IgG 1 , and IgG 2 used as the controls were from Chemicon International (Temecula, CA, USA).
Reverse transcription-polymerase chain reaction (RT-PCR)
Expression of angiopoietin-1, 2 (Ang-1, 2), Tie-2, and vascular endothelial growth factor (VEGF) and ␤-actin genes was detected by the reverse transcription polymerase chain reaction (RT-PCR) method as previously described. 21 PCR was performed by using cDNA reverse-transcribed from 200 ng of total RNA in the following conditions: 1 min at 94°C, 2 min at 60°C, 2 min at 72°C (27 cycles) for Ang-1, 2, Tie-2 and Leukemia VEGF; 1 min at 94°C, 1 min at 60°C, 2 min at 72°C (23 cycles) for ␤-actin. In each experiment, these cycles were preceded by 10 min incubation at 95°C to activate the AmpliTaq GOLD (Roche Molecular Systems, Branchburg, NJ, USA), and followed by 7 min of 72°C for final extension. Primers for PCR are listed in Table 1. 12,22-25 Products of RT-PCR, electrophoresed in 3.5% agarose, were stained with ethidium bromide and visualized by UV light. The intensity of the band was calculated by densitometer.
Cell culture
Human umbilical vein endothelial cells (1.5 × 10 4 ) (HUVEC)/cm 2 culture dish were plated, then after 2 days, leukemia cells (4.0 × 10 5 cells/ml) were added on the culture. Simple culture of leukemia cells was started simultaneously. Table 1 The primers for PCR
Ref. ␤-actin sense 5Ј-GTGGGGCGCCCCAGGCACCA-3Ј 25 antisense 5Ј-GTCCTTAATGTCACGCACGATTTC-3Ј
Figure 2
Expression of RNA for angiopoietin-1, -2, Tie-2 and VEGF in association with CD7 or t(8;21). Left panels (a, c, e, g) show the comparisons of RNA expression between CD7(+) AML and CD7(−) AML. Right panels (b, d, f, h) shows the comparison between t(8;21)(+) AML and t(8;21)(−) AML. Each data point depicts the mean of the expression levels by the densitometric data of each molecule, standardized by ␤-actin. Each box shows ±1 s.e., and each bar ±1.96 s.e. P value is shown in each panel. NS, not statistically significant.
After 10 days co-culture, leukemia cells were harvested and the cell number was counted. The medium, EBM-2, used in this co-culture study contained hydrocortisone, basic fibroblast growth factor, VEGF, insulin-like growth factor-1, ascorbic acid, fetal bovine serum (5%) and epidermal growth factor (BioWhittaker, Walkersville, MD, USA).
Cell cycle analysis of cell line cells after co-culture on HUVEC
KG-1 or KG-1a cells (1.0 × 10 5 cells/ml) were co-cultured for 24 h on the HUVEC. In the case of KG-1a, co-culture containing TIE-2/FC (which binds to angiopoietins; Sigma, St Louis, MO, USA) at the concentration of 1 g/ml or 5 g/ml was also done simultaneously. Then, the cell cycle was analyzed by using In Situ Cell Proliferation Kit, FLUOS (Roche Diagnostics, Mannheim, Germany). Briefly, 5-bromo-2Ј-deoxyuridine (BrdU) was added to the culture at the concentration of 10 M for 60 min. Then, the cells were harvested gently without tearing HUVEC from the dish. The cells were fixed in 15 mM glycine and 70% ethanol for 30 min at 4°C, denatured in 4 M HCl for 10 min at room temperature, then incubated in PBS containing 0.5% bovine serum albumin (BSA) and 0.1% Tween20 for 10 min at room temperature. Anti-BrdU-FLUOS antibody was added and incubated for 45 min at 37°C in a humid chamber. After the addition of 1 g/ml propidium iodide (PI), the cell cycle of the cell line cells was analyzed by flow cytometer. Simple culture of both cell lines was also subjected to cell cycle analysis. Cells having green fluorescence (BrdU) intensity beyond the negative control level were considered to be in S phase. Negative BrdU fluorescence with high PI fluorescence were considered to be in G 2 /M phase and negative BrdU fluorescence with low PI fluorescence in G 0 /G 1 phase.
Leukemia
Figure 4
The effect of HUVEC for the survival of AML cells. The ratio of viable AML cells on the HUVEC/viable AML cells of simple culture at day 10 were compared between CD7(+) and CD7(−) AML cells. Each data point depicts the mean of the ratio. Each box shows ±1 s.e., and each bar ±1.96 s.e. P value is shown in the panel.
Statistical analysis
Differences among subtypes of AML were evaluated by t-test. The statistical analyses were performed with the STATISTICA software program (StatSoft Inc, Tulsa, OK, USA). 
Results
Expression of mRNA for angiopoietin-1, 2 (Ang-1, 2), Tie-2, vascular endothelial growth factor (VEGF) in AML samples
mRNA expression for ang-1, 2, Tie-2 and VEGF was detected in 27, 12, 15 and 21 of 36 AML cells examined, respectively (34 AML cells were tested in the case of VEGF) (Figure 1 ). Significant difference of frequency of mRNA expression among the FAB categories was not seen except for the difference of Tie-2 between M2 (8/12) and M1 (3/12) or M3 (0/3) cases (P Ͻ 0.05) as shown in Table 2 . Frequency of expression in association with phenotypes and karyotypes is shown in Table 3 . Ang-2 mRNA expression was more frequently observed in CD7(+) AML cells than in CD7(−) AML cells. Other phenotypic markers such as CD34, CD19, CD13 and CD33 did not affect the frequency of mRNA expression for Ang-1, 2, Tie-2 or VEGF. As for the karyotypes, AML cells carrying t(8;21) chromosome abnormality showed less frequent expression of Ang-2. AML cases with t(15;17) were too few to evaluate statistically.
Ang-1, 2, Tie-2, VEGF mRNA expression in association with CD7 or t(8;21) abnormality
Since the difference of frequency was observed in association with CD7 or t(8;21), intensity of each mRNA expression was compared between CD7(+) and CD7(−) cases, or t(8;21)(+) and t(8;21)(−) cases (Figure 2 ). Tie-2 mRNA expression was weaker in CD7(+) cases than in CD7(−) cases (P Ͻ 0.05). Ang-1 and Ang-2 expression was stronger in CD7(+) cases than CD7(−), although the difference was not statistically significant. In addition, t(8;21) AML cases showed weaker expression of Ang-1 and 2, however, without statistical significance. Intensity of VEGF mRNA expression was not influenced by CD7 expression or the presence of t(8;21) abnormality.
Expression of integrin-family adhesion molecules
Expression of integrin-family adhesion molecules (CD11b, CD11c and CD18), known to be important for the interaction between hematopoietic and endothelial cells, was studied by Cell cycle analysis of KG-1 and KG-1a (simple culture vs co-culture on HUVEC) After 24 h co-culture on HUVEC, 10 M BrdU was added to the culture for 60 min, then the cells were fixed and denatured. Anti-BrdU-FLUOS antibody was applied and stained with 1 g/ml propidium iodide, then the cells were analyzed by two-color flow cytometry. In the case of KG-1a, the co-culture containing TIE-2/FC (1 g/ml or 5 g/ml) was also done simultaneously.
Table 3
Frequency of expression in association with phenotypes and karyotypes flow cytometry. As shown in Figure 3 , expression of CD11c and CD18 was more intensely expressed in CD7(+) cases than CD7(−) cases with statistical significance. On the other hand, t(8;21) AML cells showed less expression of CD11b, CD11c and CD18 than non-t(8;21) AML cells.
Angiopoietin
Co-culture of AML cells and human umbilical vein endothelial cells (HUVEC)
Leukemia cells cultured for 10 days on the monolayer of HUVEC were harvested and the number of viable cells were estimated. The ratio of viable cells on HUVEC/viable cells of simple culture were compared. As shown in Figure 4 , the ratio was significantly higher in CD7(+) AML cells (four cases) than in CD7(−) AML cells (five cases) (P Ͻ 0.05).
Leukemia
Study of KG-1 and KG-1a
An immature AML cell line, KG-1 and its variant subline KG1a were also studied. Phenotypes of these two cell lines were quite similar except for CD7 expression, which was positive for KG-1a and negative for KG-1 (Figure 5a ). Expression of mRNA for Ang-1, Ang-2 and Tie-2 of KG-1 and KG-1a was depicted in Figure 5b . Ang-1 mRNA was distinctly detected in both cell lines, although Ang-2 was expressed only in KG1a. Tie-2 mRNA expression was weakly detected in KG-1, but was not detected in KG-1a. The cell cycle study using BrdU and propidium iodide demonstrated that KG-1a cells, but not KG-1 cells, increased S/G 2 /M phase cell population by co-culture on HUVEC. The increase of S/G 2 /M phase cells of KG-1a was cancelled by the addition of TIE-2/FC in a dosedependent manner ( Figure 6 ).
Discussion
We described here the expression pattern of angiogenic factors (Ang-1, -2 and VEGF), Tie-2 receptor and integrin family adhesion molecules in various types of AML cells. Our results demonstrated that CD7(+)AML expressed Ang-2 mRNA frequently and integrin-family adhesion molecules (CD11c and CD18) intensively, suggesting the close correlation with endothelial cells. On the other hand, in t(8;21) AML cells, expression of Ang-2 was infrequent and expression of integrinfamily adhesion molecules (CD11b, CD11c and CD18) was weak, suggesting the sparse association with endothelial cells. It has been demonstrated that both normal hematopoiesis and leukemogenesis are closely correlated with endothelial cells in bone marrow. 4, 5, [7] [8] [9] However, precise mechanisms for the interaction have not been elucidated. CD7(+)AML cells often show blastic morphology, and t(8;21)AML is well known to have a tendency for prominent granulocytic differentiation. It is of interest that CD7(+)AML and t(8;21)AML showed good contrast in expression of molecules associated with interaction with endothelial cells. In addition, CD7(+)AML cells were revealed to survive on HUVEC longer than CD7(−) AML cells. This finding confirmed the close association between CD7(+)AML cells and endothelial cells functionally. One possible explanation for this contrast is that leukemia cells having close association with endothelial cells maintain immaturity and blastic morphology. 26, 27 On the other hand, leukemia cells having less association with endothelium tend to differentiate to mature cells.
As for CD7(+)AML cells, despite the frequent and intense expression of endothelial cell-associated molecules (such as Ang-2, CD11c and CD18), intensity of Tie-2 expression was quite low (P Ͻ 0.05). (Tie-2 has been demonstrated to be expressed in normal hematopoietic cells and some immature leukemic cells. 28, 29 ) Here, Ang-2 expressed in CD7(+)AML cells is not considered to act in an autocrine fashion, but to work on endothelial cells to 'feed' leukemia cells. It has been reported that Ang-2 is recognized as a natural antagonist for Tie-2. 12 However, our data presented here suggested the alternative role of Ang-2 in the relationship between endothelial cells and leukemia cells, at least in a subset of leukemia such as CD7(+)AML. Ang-2 can act as a direct stimulator for Tie-2 receptor, which augments the leukemia-endothelium interaction.
The study using KG-1 (CD7-negative) and its subline KG1a (CD7-positive) corresponded well to the results obtained from clinical materials. First, Ang-2 expression was detected only in KG-1a, and Tie-2 expression was detected in KG-1 and was not detected in KG-1a. Second, by the contact with HUVEC, KG-1a cells increased S/G 2 /M phase population, and the effect was cancelled by TIE-2/FC. The result indicated that angiopoietins (especially Ang-2) secreted by KG-1a were bound to TIE-2/FC, resulting in the disconnection between KG-1a and HUVEC and loss of 'feeding' KG-1a cells by HUVEC. Further study should be done to clarify the relationship between leukemia cells and endothelial cells through angiogenic factors.
